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AbstrACt
Objectives Self-management support aims to give people 
with chronic disease confidence to actively manage their 
disease, in partnership with their healthcare provider. A 
meta-review can inform policy-makers and healthcare 
managers about the effectiveness of self-management 
support strategies for people with type 2 diabetes, and 
which interventions work best and for whom.
Design A meta-review of systematic reviews of 
randomised controlled trials (RCTs) was performed 
adapting Cochrane methodology.
setting and participants Eight databases were 
searched for systematic reviews of RCTs from January 
1993 to October 2016, with a pre-publication update in 
April 2017. Forward citation was performed on included 
reviews in Institute for Scientific Information (ISI) 
Proceedings. We extracted data and assessed quality with 
the Revised-Assessment of Multiple Systematic Reviews 
(R-AMSTAR).
Primary and secondary outcome measures Glycaemic 
control as measured by glycated haemoglobin (HbA1c) 
was the primary outcome. Body mass Index, lipid 
profiles, blood pressure and quality of life scoring were 
secondary outcomes. Meta-analyses reporting HbA1c were 
summarised in meta-forest plots; other outcomes were 
synthesised narratively.
results 41 systematic reviews incorporating data 
from 459 unique RCTs in diverse socio-economic and 
ethnic communities across 33 countries were included. 
R-AMSTAR quality score ranged from 20 to 42 (maximum 
44). Apart from one outlier, the majority of reviews 
found an HbA1c improvement between 0.2% and 0.6% 
(2.2–6.5 mmol/mol) at 6 months post-intervention, but 
attenuated at 12 and 24 months. Impact on secondary 
outcomes was inconsistent and generally non-significant. 
Diverse self-management support strategies were 
employed; no single approach appeared optimally 
effective (or ineffective). Effective programmes tended to 
be multi-component and provide adequate contact time 
(>10 hours). Technology-facilitated self-management 
support showed a similar impact as traditional approaches 
(HbA1c MD −0.21% to −0.6%).
Conclusions Self-management interventions using a 
range of approaches improve short-term glycaemic control 
in people with type 2 diabetes including culturally diverse 
populations. These findings can inform researchers, policy-
makers and healthcare professionals re-evaluating the 
provision of self-management support in routine care. 
Further research should consider implementation and 
sustainability. 
IntrODuCtIOn  
The burden of type 2 diabetes is a promi-
nent global health challenge currently esti-
mated to affect 415 million adults worldwide1 
with greatest prevalence among socio-eco-
nomically deprived populations and those 
of African, Afro-Caribbean, South Asian 
and Middle Eastern ethnicity.2 An increas-
ingly obese, sedentary, ageing population is 
expected to drive this number up to an esti-
mated 642 million (one adult in 10) by 2040.2 
Healthcare service providers, commissioners 
and policy-makers must meet the increasingly 
complex needs and expectations of diverse 
patient populations with type 2 diabetes 
despite limited resources.
Supported self-management aims to give 
people with chronic disease confidence in 
taking an active role in all aspects of their 
strengths and limitations of this study
 ► Meta-reviews provide a high-level overview of evi-
dence ideal for informing policy and health service 
development, but fine-grained detail is lost as ran-
domised controlled trials (RCTs) are synthesised into 
systematic reviews and then meta-reviews.
 ► A comprehensive search strategy in line with a pre-
defined protocol was used to gather a large evidence 
base examining the impact of diverse self-manage-
ment support interventions on different type 2 dia-
betes populations from 1993 to 2017.
 ► Individual RCTs may be included in multiple sys-
tematic reviews; this precludes meta-analysis and 
means that that some RCTs may be over-represent-
ed in our synthesis; we have identified and report 
this overlap.
 ► The research team encompassed public health, 
statistics, epidemiology, primary care and health 
psychology expertise, enabling a multi-disciplinary 
approach to interpretation.
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disease management, and health behaviours,3 in partner-
ship with their care-providers.4 It is promoted as a strategy 
that can cost-effectively enable patients to contribute to 
the improvement of their own outcomes and plays a key 
role in the WHO’s Innovative Care for Chronic Condi-
tions (ICCC) framework.5 The increasing literature in this 
area may overwhelm decision-makers seeking to under-
stand how best to support patients with type 2 diabetes.6 
A meta-review of systematic reviews can provide a broad, 
high-level, over-arching synthesis of the existing evidence 
base in a single manuscript to inform policy, research and 
practice.6 The review questions were: Do self-manage-
ment support interventions improve glycaemic and other 
physiological outcomes for people with type 2 diabetes in 
comparison to usual care? What works, for whom and in 
what contexts?
MethODs
We adapted Cochrane methodology to conduct a meta-re-
view of systematic reviews of randomised control trials 
(RCTs) examining self-management support in people 
with type 2 diabetes.7 Reporting follows the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) guidelines.8 The initial search (January 
1993 to June 2012), undertaken as part of the Practical 
Systematic Review of Self-Management Support for long-
term conditions (PRISMS) meta-review,9 was updated in 
October 2016, and a pre-publication update completed 
in April 2017. Meta-reviews cannot be registered with the 
International Prospective Register of Ongoing System-
atic Reviews (PROSPERO) but the PRISMS protocol is 
available online: https://www. journalslibrary. nihr. ac. uk/ 
programmes/ hsdr/ 11101404/#/.
Data sources and search strategy
The participants, interventions, comparators, outcomes 
and settings (PICOS) search strategy8 (table 1) combined 
terms for: ‘self-management support’ AND ‘diabetes’ AND 
‘systematic review’ and limits specified (human subjects, 
English language, published after 1st January 1993) 
(online supplementary table 1). We searched MEDLINE, 
EMBASE, CINAHL, PsychINFO, AMED, BNI, Cochrane 
Database of Systematic Reviews and Database of Abstracts 
for Reviews of Effectiveness (DARE). A forward citation 
was carried out on all included reviews in ISI Proceedings 
(Web of Science) at the time of the database searches and 
subsequently as a pre-publication update. This approach 
is an efficient way to update searches.10
Table 1 PICOS search strategy and sources for the review
Definition
Population Adults with type 2 diabetes from all social and demographic settings. Multi-condition studies included if 
possible to extract type 2 diabetes data separately.
Intervention Self-management support interventions.
We defined self-management as: 'The tasks that individuals must undertake to live with one or more 
chronic conditions. These tasks include having the confidence to deal with medical management, role 
management and emotional management of their conditions’.3 This definition implies action on the part of 
the individual.
We defined self-management support interventions as ‘any interventions that facilitates self-
management’, that is, professional or non-professional care-givers collaboratively assisting individuals 
to manage the medical, role or emotional components of their type two diabetes. Interventions that 
solely provide one-way instructions to participants were not classified as self-management support 
interventions.
We specified that supported self-management interventions would be multi-component, so that a 
mono-component intervention (eg, exercise training) would be excluded unless it also offered (say) self-
management education giving people confidence to exercise in everyday life.
Comparator Generally usual care or less intense self-management interventions.
Outcomes Primary: HbA1c, Secondary: biomedical markers: body mass index/weight, lipids, complications. Patient 
reported: quality of life. Intermediate: self-efficacy, self-management behaviours.
Settings Any healthcare settings.
Study Design Systematic review of randomised control studies.
Dates Initial database search: January 1993 to August 2012; Update search October 2016; Pre-publication 
forward citation April 2017.
Databases MEDLINE, EMBASE, CINAHL, PsychINFO, AMED, BNI, Cochrane Database of Systematic Reviews, 
Database of Abstracts of Review of Effects and ISI Proceedings (Web of Science).
Forward citations On all included systematic reviews. Bibliographies of eligible reviews.
In progress studies Abstracts were used to identify recently published trials.
Other exclusions Previous versions of updated reviews.
Papers not published in English.
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study selection
Table 1 gives the definitions that we used to identify relevant 
reviews: in summary, we included reviews of interventions that 
supported individuals to actively manage the medical, role or 
emotional components of their type 2 diabetes.3 4 Following 
training, title and abstracts from the original PRISMS search 
were screened using the exclusion criteria online supple-
mentary table 2 (HLP) with a 10% random check (GP, EE) 
with 96% agreement; the update search was screened (MC) 
with a 1% check (GP) with 97% agreement. Disagreements 
were discussed with a third reviewer (HLP, SJCT or SW) 
until consensus was reached. The full texts were screened 
(original: HLP, GP, EE, update: MC) with 10% check in the 
original review (HLP or SJCT) with 89% agreement, and 
100% checked in the update (HLP) with 93% agreement. 
Any disagreements were resolved in discussion with a third 
reviewer (HLP, SJCT or GP).
Data extraction and quality assessment
Using a piloted form, data were extracted on: review 
rationale, review methodology, inclusion criteria, partic-
ipant demographics and intervention details, outcomes 
and conclusions as synthesised by the review authors. 
Only data provided in systematic reviews were extracted; 
data were not extracted from individual RCTs within 
systematic reviews. Data extraction was undertaken (HLP 
original; MC update) with a 10% check of extraction and 
quality assurance (GP, EE) and a 100% check of numer-
ical data extracted (GP, HLP). Methodological quality was 
assessed (HLP, MC) using the R-AMSTAR tool (Revised - 
A MeaSurement Tool to Assess systematic Reviews)11 with 
a 10% check (GP, EE). Papers were defined as very high 
quality if their score was ≥40, high quality if their score 
was ≥35, medium quality if their score was ≥30 and low 
quality if their score was less than 30. Publication bias, if 
reported in systematic reviews, was noted.
Data synthesis and analysis
The primary outcome was HbA1c (or other measure of 
glycaemic control). Secondary outcomes included: other 
biomedical markers of disease (blood pressure (BP), lipid 
profile, weight and body mass index (BMI); quality-of-life; 
intermediate outcomes (health behaviour or self-efficacy).
In addition to the definition of self-management and 
self-management support that were used to select relevant 
studies (table 1), we also used the PRISMS Taxonomy of 
Self-Management Support12 to identify self-management 
components within systematic reviews, even if the term 
‘self-management’ was not used explicitly. The taxonomy 
also provided a consistent language to describe the inter-
ventions in the included RCTs and to identify components 
used. Meta-analysis is inappropriate at the meta-review 
level because of overlap of RCTs included in the system-
atic reviews; therefore narrative synthesis was undertaken. 
For the primary outcome (HbA1c), the summary data 
from the meta-analyses in the included reviews were illus-
trated using meta-forest plots.
Patient and public involvement and stakeholder engagement
Our lay collaborator, people with long-term conditions, 
representatives of patient organisations as well as profes-
sional stakeholders (clinicians, healthcare managers and 
policy-makers) contributed to workshops throughout 
the PRISMS programme of reviews.9 Their opinions 
informed the decision about the focus of core reviews. 
At an end of project workshop, patients and other stake-
holders provided feedback on the findings, informed 
our interpretation and suggested practical approaches to 
dissemination.
results
The PRISMA diagram (figure 1) details the search 
and selection process. We identified 28 143 references 
(14 839 in the original PRISMS search and 13 304 in 
the 2016 update). After screening, 41 systematic reviews 
were included in the review: 17 papers from the orig-
inal review,13–22 24 papers from the update23–46; and two 
identified from other sources47 48; in addition, two of the 
originally included systematic reviews were replaced by 
updates.49 50 See online supplementary table 3 for the 
reviews excluded at the Update full text screening. There 
were 459 unique RCTs reported in the included system-
atic reviews; the overlap of RCTs between the reviews is 
illustrated in online supplementary figure 1.
summary of included reviews
The 41 included systematic reviews encompassed RCTs 
from 33 countries: Argentina, Australia, Austria, Bahrain, 
Canada, China, Costa Rica, Croatia, Cuba, Denmark, 
Finland, Germany, Hong Kong, Iceland, India, Iran, 
Ireland, Israel, Italy, Japan, Mexico, New Zealand, South 
Korea, Spain, Sweden, Taiwan, Thailand, the Nether-
lands, Turkey, UK, USA, Vietnam and the West Indies. 
Year of publication ranged from 2001 to 2016, with the 
RCT publications ranging from 1981 to 2015 (online 
supplementary table 4). The majority of reviews (26/39) 
included a meta-analysis,13–15 19 22–24 27–33 35–38 40 45–48 51–53 
with the remaining 15 presenting a narrative synthesis.
Intervention duration and follow-up duration were 
not always clearly defined. Where recorded, the average 
number of sessions ranged from 1 to 10 sessions, 
average contact time ranged from 30 min to 58 hours, 
over 6 weeks to 2 years (online supplementary table 
4).15–18 21 24 26 28 31 32 35 36 40–48 51–54 Twenty-one systematic 
reviews explicitly documented the follow-up duration of 
their included RCTs.19 22 24 25 27 29–37 39 40 45 46 48 52 53 The 
modal follow-up ranged from immediately after the inter-
vention to 5 years.
Quality assessment
The quality of the reviews ranged from 2047 to 4224 from a 
R-AMSTAR total of 44 (online supplementary table 4 and 
5). Four systematic reviews were very high quality,18 24 26 27 12 
were judged high quality,14 15 19 23 28 35 37 43 45 48 52 53 15 reviews 
were judged medium quality13 17 22 29–31 33 36 38 39 41 42 44 46 54 
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and 10 were low quality.16 20 21 25 32 34 40 47 51 55 Total number 
of patients in each review ranged from 64 to 33 124. Overall 
nine systematic reviews stated no publication bias had 
been found.14 23 29 36 38–40 45 48 Bolen et al found publication 
bias but noted no change after sensitivity analysis, 12 iden-
tified possible publication bias13 15 19 24 25 28 30 33 37 39 43 46 and 
16 did not assess publication bias16 17 20–22 31 32 34 41 42 47 51–55; 
three reviews stated insufficient studies to carry out mean-
ingful assessment of publication bias.18 26 27
Overview of results
Does supported self-management improve outcomes for 
people with type 2 diabetes?
Primary outcome: HbA1c
Thirty-five of 41 systematic reviews assessed glycaemic 
control, 24 of these presented meta-analyses of HbA1c 
data (online supplementary table 6). Follow-up periods 
varied between 0 and 24 months and were undefined in 
eight of the 22 reviews.13 15 23 28 30 33 37 38 Eleven system-
atic reviews presented narrative findings on glycaemic 
control.17 20 21 25 26 34 41 42 44 54 55 Ten of the 11 narrative reviews 
were low or medium quality17 20 21 25 34 41 42 44 54 55while 
18 of the 24 meta-analyses were medium or high 
quality.13–15 19 23 28–31 33 35–38 45 48 52 53
All but one meta-analysis53 found a statistically signif-
icant improvement in HbA1c following a self-manage-
ment intervention (figure 2). The HbA1c decrease in 17 
of these reviews was less than 0.5% (5 mmol/mol); three 
reviews reported a decrease between 0.5% (5 mmol/
mol) and 1% (11 mmol/mol).19 22 28 One low-quality 
review reported an decrease of 1.2% (13 mmol/mol) 
with wide confidence intervals.40 Three reviews reported 
effect sizes (thus were not included in the meta-forest 
plot) showing a significant reduction in HbA1c.30 45 47 Six 
of the 11 narrative reviews confirmed a positive effect on 
HbA1c17 20 21 25 34 41; five reported an inconsistent effect 
on HbA1c.
The comparator group in the RCTs varied both within 
and between systematic reviews and ‘usual care’ was not 
always specified. Two reviews performed sub-set analyses 
based on the nature of the control intervention.38 48 Both 
found a greater mean difference (intervention/control) 
when control was usual care than when the control was a 
minimal self-management intervention. However, classi-
fying reviews based on whether they specified a usual care 
comparator as opposed to a minimal care intervention 
showed no obvious pattern in HbA1c (online supplemen-
tary figure 2a,b).
short-term, medium-term and long-term hbA1c outcomes
Where follow-up times were differentiated in the system-
atic reviews, they are illustrated in figure 3a-c. This 
series of forest plots illustrates that the effect on HbA1c 
attenuated with time; a statistically significant effect 
persisted for 6 months in four of six reviews19 24 27 52 and 
for 12 months in three of six reviews.24 45 52 Attridge et 
al (the highest quality systematic review 42/44) was one 
of two reviews showing an improvement in HbA1c that 
persisted at 24 months follow-up.24 52 Fewer RCTs were 
included in the meta-analyses for long-term outcomes; 
at the 24 month follow-up, only one meta-analysis 
included data from more than 4 RCTs.14 Three narra-
tive reviews17 21 22 reported decreasing effectiveness over 
time.
secondary outcomes
Biomedical markers
Nine systematic reviews presented meta-analysis data of 
biomedical markers13 15 24 27 35 48 52 53 ; eight presented 
narrative data.17 21 25 26 34 42 44 54 Self-management support 
generally had no significant effect on BMI, weight and 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram.
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BP (online supplementary table 4 and 6), though 
one positive review considered that effective interven-
tions involved regular contact, reinforcement or short 
follow-up periods.31
 ► Seven of eight meta-analyses found a non-signifi-
cant decrease in BMI or weight.13 15 23 24 27 52 53 One 
found evidence of a small sustained decrease in BMI 
(0.51 kg/m2) that was attenuated but still significant 
at 12 months.48 Two reviews found evidence of a small 
but statistically significant decrease in weight.35 47 
Narrative results17 21 26 42 44 54 were similarly inconsistent 
with only two showing a short-term improvement.21 26
 ► No statistically significant evidence of BP change was 
found in three meta-analyses.24 52 53 Three found a 
clinically small but statistically significant decrease in 
systolic BP.35 47 48 The majority of narrative syntheses 
also showed insignificant improvements or mixed 
results.17 21 25 26 42 44
 ► Meta-analysis of lipid profiles showed non-signif-
icance,24 27 52 53 clinically small change,48 or were 
conflicting.35 Narrative reviews generally found no 
effect25 42 44 or small improvements.17 34
Patient-reported quality-of-life
Four systematic reviews presented meta-analysis data 
for quality of life24 46 48 52 and four provided narra-
tive results.18 20 21 53 None showed an adverse effect, 
most showed mixed, neutral or non-significant 
improvements,18 20 21 24 48 52 53 though one meta-analysis 
showed beneficial effects.46 There was some evidence 
from narrative syntheses to suggest that aspects of quality 
of life improved in response to group, peer or intensive 
interventions.18 20 21 53 There was significant heterogeneity 
in the RCTs with a variety of validated and un-validated 
questionnaires, tools and scales, making it difficult for 
review authors to draw firm conclusions.24
self-efficacy and health behaviour change outcomes
Two studies performed meta-analysis of self-efficacy. These 
showed inconsistent24 or short-term positive effects.52 
Narrative reviews (n=5) generally reported short-term 
positive effects in a few RCTs,25 26 34 42 and one showed 
unclear evidence.18
Health behaviour change outcomes encompassed diet, 
physical activity, self-measurement of blood glucose, 
recognition of complications, foot care and medication 
adherence behaviours. Three meta-analyses found a small 
but statistically significant improvement.32 47 52 In nine 
narrative reviews, there was evidence regarding improve-
ment in diet16 20 21 25 34 44 or physical activity16 21 25; however, 
overall the evidence was conflicting. Mixed results were 
reported on changes in foot-care behaviours,16 18 20 43 
though one review of intensive tailored foot-care educa-
tion showed benefit, compared with basic foot-care 
education.43
Figure 2 Meta-Forest plot of mean difference in HbA1c (variable time-points).
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What were the optimal components of self-management 
support interventions?
Self-management support interventions was coded into 
the 14 categories of the PRISMS taxonomy of self-man-
agement support12 (table 2). The most commonly used 
components were information about the condition and 
its management (32 reviews), psychological strategies (24 
reviews) and lifestyle advice and support (24 reviews). No 
component emerged as ‘essential’ or ‘optimal’, and six 
reviews advised multicomponent self-management strate-
gies.16 20 26 31 35 47 Two reviews concluded that components 
aimed at increasing motivation and changing attitudes 
were more important than enhancing knowledge.21 29
Intensity of the intervention
Generally, review authors concluded that intensity of the 
intervention influenced effectiveness. Five reviews iden-
tified that effective interventions provided moderate/
high frequency of contacts,27 28 44 47 52 though only two 
gave specific guidance (‘over 11 hours’48 ; ‘23.6 hours’ 
to achieve 1% (10.9 mmol/mol) HbA1c reduction’.22 
Nine reviews recommended longer duration of inter-
ventions,19 24 30 31 35 36 46 47 52 however, guidance for 
optimal duration varied from 3 months,24 36 over 
6 months19 31 52 to 2 years35 with regular reinforcement 
identified as important in seven studies.21 31 33 36 40 47 51 Two 
studies found intense short duration interventions to be 
more effective if reinforcement was provided.14 27
Mode of delivery
Mode of delivery is an over-arching dimension of the 
PRISMS taxonomy. Diverse interventions were deliv-
ered by a broad range of professionals and lay people to 
groups, individuals, in person or remotely with varying 
durations and intensities. There were many permutations 
of delivery within and between systematic reviews, but 
with no clear evidence of an optimal mode of delivery or 
delivery provider (online supplementary table 4).
We identified seven reviews reporting technology-facil-
itated self-management support.23 27 30 33 34 37 39 The focus 
on technology is a recent development with the earliest 
reviews published in 2013.27 33 34 Four looked at self-man-
agement education through tele-health,23 30 33 37 one eval-
uated mobile apps,37 two tested online programmes34 39 
and one included a range of technological intervention.27 
Meta-analyses23 27 30 33 37 showed an improvement in 
HbA1c similar to traditional modes of delivery.
There were conflicting findings about the relative bene-
fits of different forms of technological support, however, 
mobile app use (with/without an internet/multimedia 
approach) appeared to perform well.23 27 30 37 There were 
mixed results on whether unidirectional or bidirectional 
data transfer was better.23 30 Younger patients may do 
better.30 37
For whom are self-management support interventions 
successful?
The reviews encompassed interventions delivered 
to individuals with a broad range of demographic, 
cultural and clinical characteristics. People with poorer 
glycaemic control show greater benefit from self-man-
agement support than those whose control is already 
good.17 28 35 40 41 44 48 51 53
specific cultural groups
Nine reviews looked at culturally ‘targeted’ interventions 
(ie, generic interventions adapted to target a specific 
group)17 19 24 25 29 40 41 45 55 three reviewed culturally 
‘tailored’ interventions19 24 45 (ie, interventions compre-
hensively redesigned to fit the needs and characteristics 
of a cultural community56). Eight of the interventions 
targeted minority ethnic groups.17 19 24 25 29 40 45 55
Figure 3 Meta-Forest plot of mean difference in HbA1c 
according to duration of follow-up a: Mean difference in 
HbA1c at follow-up ≤ 6months b: Mean difference in HbA1c 
at follow-up >6months to ≤ 12months c: Mean difference 
in HbA1c at follow-up >12months to ≤24months. RCT, 
randomised controlled trial.
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Culturally targeted interventions delivery used bilin-
gual healthcare professional teams,29 community health 
workers/peer educators24 25 29 45 or bilingual comput-
er-based learning/social networking24 (table 2, online 
supplementary table 4). All five meta-analyses showed 
evidence of short-term and medium-term improvement 
in HbA1c19 24 29 40 45 though long-term benefit was incon-
sistent (figures 2 and 3a-c)
The three reviews that focused on culturally tailored 
interventions concluded that tailoring should build 
on prior research or experience of the community and 
their characteristics.19 24 45 Choi et al, in the context of a 
Chinese ethnic majority, suggested that didactic group 
lectures might be more effective and culturally accept-
able to Chinese populations than the ‘Western’ participa-
tory self-management approaches.24 40
The one review that compared cultural tailoring to 
cultural targeting concluded that interventions were 
most beneficial when tailored, and when delivered using 
a range of options by multiple educators.45 Peer educators 
were identified as a way to target existing interventions or 
inform development of a tailored intervention.24 29 45 55
specific medical groups
Targeted interventions can improve foot care behaviour 
in those at risk of foot ulceration,43 or aspects of quality 
of life for people with end-stage diabetic kidney failure18; 
however, a self-management support intervention 
targeting severe mental illness for people with diabetes 
was ineffective.26
In what contexts is self-management support best delivered?
The systematic reviews reported interventions 
carried out in a range of different settings: commu-
nity,44 45 55 outpatients,15 18 home-based, inpatient and 
remote delivery.23 39 Sixteen systematic reviews included 
a range of these settings,19 22 24 25 27–30 33–37 43 47 52 and was 
not reported in 17 reviews.13 14 16 17 20 21 26 32 38 40–42 46 48 51 53 54 
Setting was not analysed as a variable in any of the reviews, 
therefore, we cannot conclude that interventions in one 
setting were more effective than another.
DIsCussIOn
This meta-review synthesises evidence from 41 system-
atic reviews and 459 RCTs across 33 countries with 
diverse settings and healthcare systems. There is consis-
tent evidence that supported self-management improves 
glycaemic control in people with type 2 diabetes with the 
effect attenuating over time. The impact on secondary 
outcomes (BP, BMI, lipid profiles, quality of life), self-ef-
ficacy and self-management behaviours was generally 
non-significant. A wide variety of self-management support 
strategies were employed; most commonly information 
about the condition and its management; psychological 
strategies; lifestyle advice and support; and provision of 
social support. Improvement in HbA1c was demonstrated 
in diverse cultural groups, with interventions that were 
culturally, linguistically and socially appropriate. Effective 
interventions were delivered in a variety of settings, by a 
range of professionals and peer educators. Technology is 
increasingly being used and appears to be equally effec-
tive as traditional modes of delivery.
strengths and limitations
Meta-reviews enable high-level over-arching summaries 
of evidence and are therefore ideal for informing health 
service policy, but an inherent limitation is the loss of fine 
detail.57 Individual RCTs were not reviewed nor authors 
contacted for further information, so data relied on the 
quality of the systematic review publications, which in 
turn relied on the quality of RCT data. At each step, it 
was possible for assumptions to be made and detail to 
be lost. Systematic reviews had their own aims and their 
own selection criteria, which were not always completely 
aligned with the aims of this review.
Data from commonly cited RCTs were included in 
several systematic reviews so that their findings will be 
presented in multiple meta-analyses; we recognised 
this by cataloguing the overlap in RCTs included in the 
systematic reviews (see online supplementary figure 2). 
For example, one RCT was captured in seven meta-anal-
yses.58 The Forest plots thus illustrate the findings from 
each meta-analysis rather than summarising them. At 
meta-review level we were unable to exclude or control 
for publication bias, but we noted any assessments of 
publication bias by the review authors.
The update was completed with input from the majority 
of the original PRISMS team (GP, HP, SJCT and HLP) 
who were thus able to ensure fidelity to the original 
methodology. Title and abstract screening was carried 
out by one reviewer, increasing the risk of missing rele-
vant papers. Structured training, and random duplicate 
checking (95% agreement) was undertaken to maintain 
quality. The multi-disciplinary team encompassed public 
health, statistics, epidemiology, primary care and health 
psychology expertise, and met regularly to discuss results 
and aid interpretation.
Interpretation of findings
Impact of self-management on glycaemic control
Improvement in glycaemic control is a consistent and 
important finding. According to the UK Prospective 
Diabetes Study, each absolute 1% (11 mmol/mol) 
decrease in HbA1c is associated with reduction of 21% 
for any diabetes-related end point and 37% for micro-
vascular complications. Therefore, an improvement 
between 0.25% and 0.5% (3 mmol/mol to 5 mmol/mol) 
(the the most common outcome in this meta-review) is 
modest, but clinically significant59 and could make useful 
inroads into the projected burden of diabetes. This may 
underestimate the impact of supported self-manage-
ment, as many reviews accepted minimal intervention 
(such as behavioural weight programme or education) 
as a comparator, which may have had some effect in the 
control group.13 15 19 22 24 27 28 35–37 52 53 This heterogeneity 
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of comparator, however, reflects the diverse healthcare 
contexts in which interventions will be implemented 
as type 2 diabetes education or other self-management 
components may be routinely available in some settings 
but not in others.
Impact of self-management on secondary outcomes
Self-management did not consistently improve other 
physiological targets of diabetes care. This may be a 
consequence of a narrow focus on glycaemic control, 
inadequate intensity of interventions or limited ongoing 
reinforcement. Further research on strategies that might 
improve this broader range of outcomes is warranted.
Implementation: what works, for whom and in what contexts
Implementation is challenging and only a minority of 
people with diabetes receive self-management support.2 
Time pressures in routine practice may mean that infor-
mation is provided in convenient, standardised but 
potentially ineffective formats (eg, leaflets, didactic group 
lectures),21 which take no account of cultural beliefs, 
personal preferences or individual psychological adjust-
ment to their diagnosis.
It was not possible to definitively pinpoint the optimal 
composition, intensity or mode or delivery of supported 
self-management, though many studies concluded that 
effective programmes were multi-component and of 
adequate intensity (>10 hours). Attenuation of effect 
(see figure 2A–C), and the observation that prolonged 
duration and/or reinforcement are features of effective 
interventions resonates with the concept of ‘supported 
self-management’ as an approach to delivering ongoing 
care rather than a discrete time-limited intervention.
Flexibility is likely to be important,17 where a preferred 
self-management support strategy is co-constructed with 
individuals. People’s fluctuating motivation to manage 
their diabetes as they progress and oscillate through 
different physical and psychological phases related to 
their life, health and disease severity adds complexity 
to this situation. This may be best addressed by offering 
access to more intensive components (eg, comprehen-
sive self-management education courses) according to 
readiness to receive rather than chronological time since 
diagnosis.
Echoing recommendations in other disease areas,9 
authors of our included reviews highlighted the need to 
tailor interventions to individuals or diverse social and/
or cultural groupings. Characteristics of target commu-
nities, the range of professionals, peer educators, third 
sector agencies and local resources available, as well as 
the patients’ existing interaction with the diabetes care 
services should be considered when designing/devel-
oping a self-management support programmes or evalu-
ating an existing programme.
Technology may be a promising mode of delivery, 
which, in our included reviews, seemed similarly effec-
tive to traditional approaches. Intuitively, they may be 
seen as offering convenient options for hard-to-reach 
groups such as economically active younger people or 
marginalised populations reluctant to attend multiple 
lengthy appointments or formal group self-management 
programmes. Self-monitoring and professional feedback 
(potentially facilitated by tele-health) may offer other 
theoretical advantages. In the context of hypertension 
(another asymptomatic long-term condition in which the 
key medical aim of self-management is to prevent compli-
cations) qualitative evidence suggests that self-monitoring 
of physiological parameters can bridge the gap between 
a lay perspective (treating symptoms) and medical objec-
tive (improving clinical measurements) promoting a 
collaborative approach to self-management.60
Implications for research
Studies of self-management of type 2 diabetes are 
well-represented in the literature and findings are based 
on a mature and diverse database. Future RCTs should 
shift from establishing short-term effectiveness (reduced 
HbA1c) to exploring how to sustain self-management 
support in routine care. Longer term studies suggested 
attenuation of effect, but it is not clear whether this is 
the result of loss of effect of the intervention (implying 
the need for ongoing support) or the gradual increase 
of HbA1c over time making it more difficult to control.61 
Behaviour change interventions commonly show attrition 
over time and need reinforcing.62 The recognised benefit 
of achieving early control in reducing longer term micro-
vascular outcomes supports provision of self-management 
support despite this attenuation.63 These areas require 
further characterisation in studies designed for follow-up 
of long-term outcomes.
The shift in focus to implementation demands an 
understanding of the influence of context (policy incen-
tives, healthcare setting, existing approach to self-man-
agement, availability of resources) and the development 
of locally adaptable implementation strategies promoting 
sustainable support for diabetes self-management. The 
PRISMS taxonomy of self-management support12 worked 
well as a framework for clarifying description of self-man-
agement support initiatives in the different reviews and 
could act as an inventory of potential self-management 
support strategies. Consideration of the taxonomy may 
facilitate learning from self-management strategies used 
in other long-term conditions. For example, proactive 
written ‘action plans’ are pivotal in asthma self-manage-
ment64 but used less commonly in type2 diabetes, although 
could be applicable as ‘sick day rules’ for metformin.65
Qualitative evidence suggests that self-management 
support needs to evolve over time. Initial support may 
need to focus on enabling people to accept the diagnosis; 
the optimal time to focus on lifestyle change may be when 
a person has made a conscious decision to take control 
over their condition.9 Included reviews rarely used 
outcomes such as patient activation66 or self-efficacy that 
might have informed the process of behaviour change, 
suggesting a fruitful research agenda in exploring how 
people relate to their type 2 diabetes diagnosis and how 
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that influences the optimal timing, delivery, components 
and overall direction of their self-management.
While tailoring to cultural groups was addressed by the 
included reviews, other groups were under-represented, 
for example, the frail elderly, people with multi-morbidity, 
people affected by substance misuse, disability and mental 
health problems. Self-management in populations with 
limited access to healthcare services either due to depri-
vation, rurality, geography, occupation, transiency or 
incarceration are contexts that could benefit from further 
exploration. The potential of technology as a mode of 
delivering supported self-management is an important 
research agenda. As in other disease areas,60 67 our find-
ings suggest that technologically supported self-man-
agement is at least as effective as traditional face-to-face 
approaches; there is need for methodologically rigorous 
mixed-methods evaluation of the potential advantages 
to healthcare services and individuals of employing this 
mode of interaction.
COnClusIOn
Self-management support, using a range of strategies, 
improves glycaemic control at least in the short term; the 
effect on other clinical indicators such as blood pressure 
is inconsistent. Tailored interventions enable targeted 
approaches that are culturally, socially and demograph-
ically sensitive to the individual and their community. 
Implementing an adaptable self-management programme 
offering tailored sustainable self-management support 
for individuals with type 2 diabetes, which is accessible 
throughout their diabetes journey will require a whole 
systems approach that involves active involvement of poli-
cy-makers, healthcare providers, patients and third sector 
organisations. Existing assets must be identified, and new 
services designed where gaps exist.
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